<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Peptide Press — Briefing</title><description>Editorial coverage of peptide research, analytical testing, clinical studies, and regulation.</description><link>https://peptide.press/</link><language>en-us</language><item><title>How to read a peptide Certificate of Analysis</title><link>https://peptide.press/articles/how-to-read-a-peptide-certificate-of-analysis/</link><guid isPermaLink="true">https://peptide.press/articles/how-to-read-a-peptide-certificate-of-analysis/</guid><description>Identity, purity, potency, net content — what each line on a COA actually proves, walked through on a real report, and the gaps a clean-looking document can still hide.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>testing</category><category>COA</category><category>HPLC</category><category>purity</category><category>net content</category><category>quality control</category></item><item><title>Why a 99% purity result doesn&apos;t tell you what buyers think it does</title><link>https://peptide.press/articles/why-a-99-percent-purity-result-can-mislead/</link><guid isPermaLink="true">https://peptide.press/articles/why-a-99-percent-purity-result-can-mislead/</guid><description>Purity and net content answer different questions. Conflating them is the single most common way a technically honest COA leaves a buyer worse off.</description><pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate><category>testing</category><category>purity</category><category>net content</category><category>COA</category><category>quality control</category></item><item><title>Why promising peptide results in mice so often fail to translate to humans</title><link>https://peptide.press/articles/why-mouse-results-fail-to-translate/</link><guid isPermaLink="true">https://peptide.press/articles/why-mouse-results-fail-to-translate/</guid><description>Preclinical data is where most of the excitement in the peptide world originates — and where most of it should be tempered. A field guide to reading animal studies with the skepticism they deserve.</description><pubDate>Sun, 05 Jul 2026 00:00:00 GMT</pubDate><category>research</category><category>preclinical</category><category>translation</category><category>study design</category><category>research literacy</category></item><item><title>What the March 2026 FDA warning letters reveal about the limits of &quot;research use only&quot;</title><link>https://peptide.press/articles/march-2026-fda-peptide-warning-letters/</link><guid isPermaLink="true">https://peptide.press/articles/march-2026-fda-peptide-warning-letters/</guid><description>In a single day, the FDA told multiple peptide sellers that an RUO label does not control when the surrounding evidence establishes an intended human-drug use. The reasoning is worth reading closely.</description><pubDate>Thu, 02 Jul 2026 00:00:00 GMT</pubDate><category>regulation</category><category>FDA</category><category>enforcement</category><category>RUO</category><category>warning letters</category><category>intended use</category></item><item><title>How to check a compound&apos;s clinical trial status yourself</title><link>https://peptide.press/articles/reading-clinicaltrials-gov-status/</link><guid isPermaLink="true">https://peptide.press/articles/reading-clinicaltrials-gov-status/</guid><description>ClinicalTrials.gov is public, free, and the fastest way to separate a compound with real human data behind it from one riding on preclinical hype. Here&apos;s how to read a record.</description><pubDate>Sun, 28 Jun 2026 00:00:00 GMT</pubDate><category>trials</category><category>clinical trials</category><category>ClinicalTrials.gov</category><category>research literacy</category><category>phases</category></item></channel></rss>